Revelation Biosciences Inc REVB shares are trading higher after the company announced an exclusive worldwide license agreement with Vanderbilt University to develop and commercialize phosphorylated ...
SAN DIEGO--(BUSINESS WIRE)--Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on harnessing the power of trained ...
Revelation Software is launching OpenInsight Development Suite (OI) 10, introducing new development tools, increasing security, and more. “For most of Revelation’s history the OpenInsight releases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback